T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
Gastrointestinal oncology is one of the foremost causes of death: the gastric cancer accounts for 10.4% of cancer deaths worldwide, the pancreatic cancer for 6%, and finally, the colorectal cancer for 9% of all cancer-related deaths. For all these gastrointestinal cancers, surgical tumor resection r...
Main Authors: | Amedeo Amedei, Elena Niccolai, Mario M. D'Elios |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/320571 |
Similar Items
-
What Is Recent in Pancreatic Cancer Immunotherapy?
by: Elena Niccolai, et al.
Published: (2013-01-01) -
Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
by: Amedeo Amedei, et al.
Published: (2011-01-01) -
Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
by: Mario Milco D’Elios, et al.
Published: (2012-10-01) -
T Cells in Gastric Cancer: Friends or Foes
by: Amedeo Amedei, et al.
Published: (2012-01-01) -
Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects
by: Tatiana D. Khokhlova, et al.
Published: (2015-11-01)